Trials / Recruiting
RecruitingNCT05656794
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
Consolidative Prostate Radiotherapy in Patients With Metastatic Prostate Cancer
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- Male
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, randomized phase II trial investigating if radiation treatment delivered every other day for 2 weeks has the same side effects as radiation treatment delivered once weekly for 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy | Standard of care radiotherapy administered as per institutional guidelines. |
Timeline
- Start date
- 2023-08-09
- Primary completion
- 2031-08-01
- Completion
- 2031-08-01
- First posted
- 2022-12-19
- Last updated
- 2026-03-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05656794. Inclusion in this directory is not an endorsement.